PROGENITY INC

PROG NASDAQ

02:38

Apux

I am still a believer in the long term prospects for this company. I took profits because I think it may come under selling pressure when the convertible note converts to common stock. Something that will take place over the next couple weeks. // ---> Here is a paragraph from yesterdays share holder notice: The Company’s expected use of proceeds from the Notes...

05:12

Apux

Progenity has been long from $3.68. It almost hit the first take profit target of $8 intra-day. Will update the next target when that becomes support.

07:30

Apux

If you followed my prior videos you bought this trade early in this cycle. I still think some strategic moves are in play. In either case plan to hold through $8 and evaluate the technical situation then.

02:56

Apux

I had previously said that the raise they did was for something major or strategic. I still believe that and expect some announcement will be coming.

02:26

Apux

Progenity is doing what I expected up over 10% today. Once it goes north of $4.05 it should quickly work its way to $5.21 and if it holds $5.21 all the way to $8.

04:27

Apux

Here is my latest analysis of Progenity, Inc. Possible that Illumina Inc or Johnson and Johnson would want to buy this to protect their portfolio of pre-natal testing products? In either case it could play out.

06:43

Apux

I posted this idea a couple of days ago. After hours on Friday news came out via an S-4 filing with the SEC that CEO Harry Stylli bought 152,905 shares of PROG stock on the open market. He currently owns 14,616,874 shares in total.

05:14

Apux

News came out that a secondary was taking place @ fair value for this stock which is quite beat up. With an option to buy an additional 1.146 million shares at $3.27. This is extremely bullish for the short term prospects on this stock.